Replay available

Ascentage Pharma Group International (AAPG) Q2 2026 Earnings Call

Ascentage Pharma Group International (NASDAQ: AAPG) Q2 2026 earnings conference call, held 2026-08-20. Replay captured from the company's public earnings webcast.

Thu, August 20, 2026 at 9:00 AMendedReplay
Ascentage Pharma Group International (AAPG) Q2 2026 Earnings Call

Hosted by

Featured presenters

Dr. Yifan Zhai

Chief Medical Officer

Dr. Dajun Yang

Chairman and Chief Executive Officer

Sumetsun Karuneni

Director of Investor Relations and Corporate Strategy

Dr. Faisal Miara

Chief Business Officer

Jim Ziegler

Chief Commercial Officer

Dr. Veet Misra

Chief Financial Officer

Brian Chang

Analyst, JPMorgan

Byron Amin

Analyst, Piper Sandler

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Ascentage Pharma Group International.

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a03fbd-198a-7602-b3f3-b04a22c6273d Created: 2026-08-26T20:22:36.838Z Duration: 8277.48 Channels: 1 00:00:00.000 -- 00:00:01.359 Testing audio. 00:00:01.520 -- 00:00:06.720 Hello, everyone. Good morning. 1234567. 00:00:07.600 -- 00:00:08.559 Testing audio. 00:52:18.200 -- 00:52:19.800 We cannot hear anyone. 00:52:24.395 -- 00:52:25.115 Hello? 00:52:26.395 -- 00:52:28.155 Can you hear me? Hello, 00:52:28.155 -- 00:52:29.915 and welcome to the 2026 00:52:29.915 -- 00:52:31.675 interim financial results. 00:52:31.915 -- 00:52:33.675 We ask that you please hold all questions 00:52:33.675 -- 00:52:35.755 until the completion of the formal remarks, 00:52:36.110 -- 00:52:38.110 at which time you will be given instructions 00:52:38.110 -- 00:52:40.910 for the question and answer session. Also, as 00:52:40.910 -- 00:52:41.710 a reminder, 00:52:41.790 -- 00:52:43.630 this conference is being recorded. 00:52:43.790 -- 00:52:45.310 If you have any objections, 00:52:45.310 -- 00:52:47.950 please disconnect at this time. With that, I 00:52:47.950 -- 00:52:49.470 would like to turn the call over to 00:52:49.470 -- 00:52:50.990 Sumit Neni. You may begin. 00:52:52.164 -- 00:52:54.565 Thank you, operator, and good morning, everyone. Thank 00:52:54.565 -- 00:52:57.125 you for joining today. Welcome to Ascentage Pharma's 00:52:57.125 -- 00:52:59.444 twenty twenty six Interim Results and Business Update 00:52:59.444 -- 00:53:01.444 Call. I'm Sumit Sunkaraneni, 00:53:01.444 -- 00:53:03.684 Director of Investor Relations and Corporate Strategy at 00:53:03.684 -- 00:53:04.164 Ascentage. 00:53:04.830 -- 00:53:07.150 Please note that today's discussion will include forward 00:53:07.150 -- 00:53:09.310 looking statements based on our ...